Table 2.
Demographics, PH etiology and PH specific therapies. PAH pulmonary arterial hypertension, PH pulmonary hypertension
| N = 1073 | % | |
|---|---|---|
| Gender | ||
| Female | 839 | 78.2 |
| Male | 228 | 21.2 |
| No answer | 6 | 0.6 |
| PH etiology | ||
| Idiopathic PAH | 416 | 38.8 |
| Heritable/genetic PAH | 80 | 7.5 |
| Drug related PAH | 15 | 1.4 |
| Liver disease related PAH | 16 | 1.5 |
| Connective tissue disease related PAH | 93 | 8.7 |
| Congenital heart malformation related PAH | 208 | 19.4 |
| Chronic thromboembolic PH | 161 | 15.0 |
| Other | 13 | 1.2 |
| I do not know/I am not sure/Do not want to answer | 71 | 6.6 |
| Treatments | ||
| Oral | 934 | 87.0 |
| Intravenous | 76 | 7.1 |
| Subcutaneous | 77 | 7.2 |
| Inhaled | 72 | 6.7 |
| Study medication | 18 | 1.7 |
| No specific PH treatment reported | 115 | 10.7 |